| P50 | author | Letícia Tamborlin | Q87896540 |
| | Letícia Meneguello | Q87896542 |
| P2093 | author name string | Rosario D C Hirata | |
| | Augusto D Luchessi | |
| | Raul H Bortolin | |
| | Vivian N Silbiger | |
| | Mário H Hirata | |
| | André D Luchessi | |
| | Mariana B Lopes | |
| | Renata C Costa de Freitas | |
| P2860 | cites work | MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein | Q24601263 |
| | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| | MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma | Q26765476 |
| | The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19 | Q26801867 |
| | Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics | Q26822796 |
| | MicroRNA-26a acts as a tumor suppressor inhibiting gallbladder cancer cell proliferation by directly targeting HMGA2. | Q39010156 |
| | Hepatocellular toxicity of clopidogrel: mechanisms and risk factors | Q39139225 |
| | Benzo[a]pyrene-induced changes in microRNA-mRNA networks | Q39399748 |
| | Integrated analysis of miRNA and mRNA gene expression microarrays: Influence on platelet reactivity, clopidogrel response and drug-induced toxicity | Q39472122 |
| | Inhibition of SENP5 suppresses cell growth and promotes apoptosis in osteosarcoma cells | Q40240693 |
| | Clopidogrel pathway | Q41829299 |
| | Liver Effects of Clinical Drugs Differentiated in Human Liver Slices | Q41951728 |
| | Expression of miRNA-26a in platelets is associated with clopidogrel resistance following coronary stenting | Q42245649 |
| | The mechanism and risk factors of clopidogrel-induced liver injury | Q46625831 |
| | Molecular mechanisms of LKB1 induced cell cycle arrest | Q47896414 |
| | The story of clopidogrel and its predecessor, ticlopidine: Could these major antiplatelet and antithrombotic drugs be discovered and developed today? | Q56455078 |
| | Pharmacokinetics of clopidogrel | Q78106915 |
| | Paraoxonase-1 is a major determinant of clopidogrel efficacy | Q82951856 |
| | MicroRNAs as potential biomarkers for doxorubicin-induced cardiotoxicity | Q89096618 |
| | Potential for developing purinergic drugs for gastrointestinal diseases | Q27000719 |
| | The panorama of miRNA-mediated mechanisms in mammalian cells | Q27001268 |
| | Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives | Q27690772 |
| | The SUMO-specific protease SENP5 is required for cell division | Q27863924 |
| | Exosomes as miRNA Carriers: Formation-Function-Future | Q28075728 |
| | Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR | Q30984776 |
| | Biochemical and neurochemical sequelae following mild traumatic brain injury: summary of experimental data and clinical implications | Q33734932 |
| | MicroRNAs expression profiles in cardiovascular diseases | Q33821302 |
| | Down-regulation of microRNA-26a promotes mouse hepatocyte proliferation during liver regeneration | Q34229869 |
| | Effects of drug interactions on biotransformation and antiplatelet effect of clopidogrel in vitro | Q34339780 |
| | Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism | Q34536091 |
| | Characterization of human plasma-derived exosomal RNAs by deep sequencing. | Q34714581 |
| | Clopidogrel-induced liver failure | Q35017980 |
| | An idiosyncratic reaction to clopidogrel. | Q35043272 |
| | Drug-induced liver injury: the dawn of biomarkers? | Q35210890 |
| | miRNA regulation of cytotoxic effects in mouse Sertoli cells exposed to nonylphenol | Q35389756 |
| | Exosome and exosomal microRNA: trafficking, sorting, and function | Q35543884 |
| | MicroRNAs as Signaling Mediators and Biomarkers of Drug- and Chemical-Induced Liver Injury. | Q35750622 |
| | Characterization of RNA from Exosomes and Other Extracellular Vesicles Isolated by a Novel Spin Column-Based Method | Q35758580 |
| | Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options | Q35797491 |
| | Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins | Q35828228 |
| | Tousled kinase activator, gallic acid, promotes homologous recombinational repair and suppresses radiation cytotoxicity in salivary gland cells | Q35917261 |
| | Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases | Q36365092 |
| | DNA damage and eIF4G1 in breast cancer cells reprogram translation for survival and DNA repair mRNAs | Q36414762 |
| | HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis. | Q36932231 |
| | Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancers | Q37338907 |
| | Clopidogrel-induced hepatocellular injury and cholestatic jaundice in an elderly patient: case report and review of the literature | Q37461447 |
| | Effects of miR-145-5p through NRAS on the cell proliferation, apoptosis, migration, and invasion in melanoma by inhibiting MAPK and PI3K/AKT pathways | Q37747447 |
| | Developing microRNA therapeutics | Q37981141 |
| | High-content analysis in toxicology: screening substances for human toxicity potential, elucidating subcellular mechanisms and in vivo use as translational safety biomarkers | Q38196938 |
| | Thrombosis formation on atherosclerotic lesions and plaque rupture | Q38243253 |
| | The role for microRNAs in drug toxicity and in safety assessment | Q38367620 |
| | Apoptosis-related microRNA-145-5p enhances the effects of pheophorbide a-based photodynamic therapy in oral cancer | Q38403436 |
| | MicroRNA Biomarkers and Platelet Reactivity: The Clot Thickens | Q38437965 |
| | Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer | Q38764114 |
| P921 | main subject | clopidogrel | Q410237 |
| | hepatotoxicity | Q1349821 |
| P304 | page(s) | 906 | |
| P577 | publication date | 2017-12-12 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | Modulation of miR-26a-5p and miR-15b-5p Exosomal Expression Associated with Clopidogrel-Induced Hepatotoxicity in HepG2 Cells | |
| P478 | volume | 8 | |